(Q43703162)

26 November 2017

title

The African American Study of Kidney Disease and Hypertension (AASK): new findings (English)

1 reference

26 November 2017

Sica DA

1

1 reference

26 November 2017

Douglas JG

series ordinal

2

1 reference

26 November 2017

publication date

1 July 2001

1 reference

Journal of Clinical Hypertension

26 November 2017

published in

1 reference

26 November 2017

volume

3

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

244-251

1 reference

Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Cross sectional longitudinal study of spot morning urine protein:creatinine ratio, 24 hour urine protein excretion rate, glomerular filtration rate, and end stage renal failure in chronic renal disease in patients without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Proteinuria as a mediator of tubulointerstitial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Using angiotensin converting enzyme inhibitors in African-American hypertensives: a new approach to treating hypertension and preventing target-organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

Microalbuminuria and Prevention of Renal Insufficiency and Cardiovascular Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2001.00474.X

10.1111/J.1524-6175.2001.00474.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference